Highlights The COVID-19 and Epilepsy (COV-E) global surveys launched in May 2020. UK respondents (n=463) report changes in seizure frequency, mental health and sleep. Discussion of risk, including of SUDEP, was infrequent even before the pandemic. COVID-19 is having far-reaching consequences on people with epilepsy. Our study exemplifies the importance of delivering optimal care to mitigate risk.

Periodic electroencephalographic (EEG) patterns consist of discharges usually epileptiform in appearance, which occur at regular intervals, in critical patients. They are commonly classified as periodic lateralized epileptiform discharges (PLEDs), bilateral independent PLEDs or BIPLEDs, generalized epileptiform discharges (GPEDs) and triphasic waves. Stimulus-induced rhythmic, periodic or ictal discharges (SIRPIDs) are peculiar EEG patterns, which may be present as periodic discharges. The aim of this study is to make a review of the periodic EEG patterns, emphasizing the importance of their recognition and clinical significance. The clinical significance of the periodic EEG patterns is uncertain, it is related to a variety of etiologies, and many authors suggest that these patterns are unequivocally epileptogenic in some cases. Their recognition and classification are important to establish an accurate correlation between clinical, neurological, laboratorial and neuroimaging data with the EEG results.

More than 80 years after its introduction by Hans Berger, the electroencephalogram (EEG) remains as an important supplementary examination in the investigation of neurological disorders and gives valuable and accurate information about cerebral function. Abnormal EEG findings may include ictal patterns, interictal epileptiform activity and non-epileptiform abnormalities. The aim of this study is to make an overview on the main non-epileptiform EEG abnormalities, emphasizing the pathologic findings and the importance of their recognition, excluding periodic patterns and EEG physiologic changes. Scientific articles were selected from MEDLINE and PubMed database. The presence of non-epileptiform EEG abnormalities provide evidence of brain dysfunction that are not specific to a particular etiology and may be related to a number of disorders affecting the brain. Although these abnormalities are not specific, they can direct attention to the diagnostic possibilities and guide the best treatment choice. Key words: abnormal EEG, non-epileptiform abnormalities, slow activity.Anormalidades eletrencefalográficas não epileptiformes: uma visão geral RESUMO Mais de 80 anos após sua introdução por Hans Berger, o eletrencefalograma (EEG) permanece como importante exame complementar na investigação de transtornos neurológicas e fornece informações valiosas e precisas a respeito da função cerebral. Achados eletrencefalográficos anormais podem incluir padrões ictais, atividade epileptiforme interictal e anormalidades eletrencefalográficas não epileptiformes. O objetivo deste estudo é fazer uma revisão das principais anormalidades eletrencefalográficas não epileptiformes, enfatizando os achados patológicos e a importância de seu reconhecimento, excluindo padrões periódicos e alterações eletrencefalográficas fisiológicas. Foram selecionados artigos científicos por meio de pesquisa nas bases de dados MEDLINE e PubMed. A presença de anormalidades eletrencefalográficas não epileptiformes fornece evidências de disfunção cerebral, as quais não são específicas para uma etiologia particular e podem estar relacionadas a uma série de desordens que afetam o encéfalo. Embora essas anormalidades não sejam específicas, elas podem direcionar a atenção para as possibilidades diagnósticas e guiar a escolha do melhor tratamento. Palavras-Chave: EEG anormal, anormalidades não epileptiformes, atividade lenta.

The COVID-19 pandemic has had an unprecedented impact on people and healthcare services. The disruption to chronic illnesses, such as epilepsy, may relate to several factors ranging from direct infection to secondary effects from healthcare reorganization and social distancing measures. Objectives As part of the COVID-19 and Epilepsy (COV-E) global study, we ascertained the effects of COVID-19 on people with epilepsy in Brazil, based on their perspectives and those of their caregivers. We also evaluated the impact of COVID-19 on the care delivered to people with epilepsy by healthcare workers. Methods We designed separate online surveys for people with epilepsy and their caregivers. A further survey for healthcare workers contained additional assessments of changes to working patterns, productivity, and concerns for those with epilepsy under their care. The Brazilian arm of COV-E initially collected data from May to November 2020 during the country's first wave. We also examined national data to identify the Brazilian states with the highest COVID-19 incidence and related mortality. Lastly, we applied this geographic grouping to our data to explore whether local disease burden played a direct role in difficulties faced by people with epilepsy. Results Two hundred and forty-one people returned the survey, 20% were individuals with epilepsy ( n = 48); 22% were caregivers ( n = 53), and 58% were healthcare workers ( n = 140). Just under half (43%) of people with epilepsy reported health changes during the pandemic, including worsening seizure control, with specific issues related to stress and impaired mental health. Of respondents prescribed antiseizure medication, 11% reported difficulty taking medication on time due to problems acquiring prescriptions and delayed or canceled medical appointments. Only a small proportion of respondents reported discussing significant epilepsy-related risks in the previous 12 months. Analysis of national COVID-19 data showed a higher disease burden in the states of Sao Paulo and Rio de Janeiro compared to Brazil as a whole. There were, however, no geographic differences observed in survey responses despite variability in the incidence of COVID-19. Conclusion Our findings suggest that Brazilians with epilepsy have been adversely affected by COVID-19 by factors beyond infection or mortality. Mental health issues and the importance of optimal communication are critical during these difficult times. Healthcare services need to find nuanced approaches and learn from shared international experiences to provide optimal care for people with epilepsy as the direct burden of COVID-19 improves in some countries. In contrast, others face resurgent waves of the pandemic.

OBJECTIVES: To make a retrospective analysis and evaluate a clinical response to the control of disc degeneration related pain of 396 patients submitted to percutaneous lumbar nucleoplasty; and to make a record of visual analogical scale (VAS) up to a three-year follow-up after the surgical procedure. METHODS: Analysis of VAS score in 396 patients with lumbar disc degeneration related pain, according to anamnesis, clinical examination and magnetic resonance imaging (MRI), without improvement of previous clinical treatment, submitted to percutaneous nucleoplasty. RESULTS: A total of 26% of the patients presented 100% remission of pain or paresthesia, of whom 75% showed at least 50% of pain improvement. The median VAS pain improvement was about 67%. CONCLUSIONS: The median VAS improvement in inferior disc levels was higher than four points. The VAS showed improvement of the pain and paresthesia up to a three-year follow up after the surgical procedure.

The allele HLA DRB1*13:02 has exhibited a tendency to behave as a susceptibility factor for TLE-HS.

This study intended to investigate the clinical and electroencephalographic benign occipital epilepsy of childhood (BOEC) characteristics in a population sample of patients from two tertiary Brazilian hospitals. We analyzed retrospectively 4912 electroencephalograms (EEGs) records, and the included patients were submitted to a new clinical and EEG evaluation. Were included 12 (0.92%) patients; 4 (33.3%) with criteria for early BOEC; 6 (50%) for late form and 2 (16.7%) with superimposed early and late onset forms. After new investigation, 2 (16.7%) had normal EEG; 4 (33.3%) had paroxysms over the occipital region; 3 (25%) over the temporal posterior regions and 3 (25%) over the posterior regions. Sharp waves were the predominant change, occurring in 8 (66.6%); spike and slow wave complexes in 1 (8.3%) and sharp and slow wave complexes in 1 (8.3%). Vomiting, headache and visual hallucinations were the most common ictal manifestations, presented in 100% of patients with superimposed forms. Vomiting were absent in the late form and headache was present in all forms of BOEC.

A cross-sectional epidemiological study was done among a general population in a big hospital in São Paulo, Brazil. From an initial population of 1781 nursing personnel, 407 were called for a semi-structured interview based on a standard questionnaire. The average age of the interviewed population was 32.6 + 9.2 years old and 89.4% were female. Making use of the criteria of the International Headache Society, prevalence of migraine was detected in 53.1% of them (22.1% migraine without aura; 7,9% migraine with aura; 9.2% migraine with and without aura; 13.8% migrainous disorder not fulfilling criteria) The clinical criterion most related to the diagnosis of migrainous disorder was the shortest duration of the migraine crises. The high patterns of prevalence were due to populational factors (mostly female people, age, and professional activity linked to service occupation) and to factors linked to the diagnostical characterization of the type of headaches. The independent variables most related to diagnosis of migraine were family history, high levels in Epworth Sleepiness Scale and subjective perception of stress. Other variables were: gender, physical activity, exposition to vapours and type of professional activity. Half of the population who suffered headache had already looked for medical support, and only 28.6% of doctors got to adequate diagnoses. Once the social importance of the prevalence of migraine among this populational group, populational impact measures are proposed.